Nano Dimension has a new announcement: the 3D printed electronics leader is creating a new subsidiary, in order to advance its 3D bioprinting initiative. Nano Dimension has been conducting market research into applications of its 3D bioprinting technology, and says that it will now be developing a platform to 3D bioprint both connective tissues and cells, which will be used to create biological structures that will function as human kidneys. The subsidiary will focus mainly on developing solutions for end stage renal diseases (ESRD) which ultimately lead to kidney failure. Read more at 3DPrint.com: https://3dprint.com/164809/nano-dime...nt-subsidiary/